Value in HealthVolume 18, Issue 3, May 2015, Pages A121-A122PMH40 - Cost-utility of Vortioxetine versus Venlafaxine xr in the treatment of Major depressive Disorder in South KoreaAuthor links open overlay panelJung R. 1, Brignone M. 2, Campbell R. 3, François C. * 4, Milea D. 5Show moreShareCitehttps://doi.org/10.1016/j.jval.2015.03.712Get rights and contentUnder an Elsevier user licenseopen archivePrevious article in issueNext article in issueRecommended articlesCited by (0)Copyright © 2015 Published by Elsevier Inc.